Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL

10.1056/NEJMoa022457

10.1182/blood-2003-11-3800

10.1182/blood-2003-09-3363

10.1182/blood-2004-04-1389

10.1182/blood-2001-12-0181

Ottmann OG, 2003, Blood, 102, 226a

10.1182/blood-2003-08-2958

10.1002/cncr.21299

10.1158/1078-0432.CCR-04-2601

10.1158/0008-5472.CAN-05-0259

Manley P, von Bubnoff N, Duyster J, et al. AMN107: inhibitory profile against wild-type and mutant forms of the BCR-ABL tyrosine kinase. Presented at the 96th annual meeting of the American Association for Cancer Research, Anaheim, Calif., April 16–20, 2005.

Faderl S, 1999, Ann Intern Med, 131, 207, 10.7326/0003-4819-131-3-199908030-00008

10.1002/1097-0142(19880401)61:7<1441::AID-CNCR2820610727>3.0.CO;2-C

10.1016/0002-9343(87)90754-6

10.1056/NEJMoa011573

10.1182/blood-2002-09-2790

10.1081/BIP-100100998

10.1182/blood.V99.10.3547

10.1158/1078-0432.CCR-04-2139

Cohen MH, 2005, Clin Cancer Res, 11, 12, 10.1158/1078-0432.12.11.1

10.1056/NEJM199511023331802

10.1200/JCO.2003.11.143

10.1056/NEJMoa055229